rs10514168 — TSHZ1

TSHZ1 and Constitutional Vestibular Susceptibility to Motion Sickness

About one in three people is highly susceptible to motion sickness — nausea, dizziness, and malaise triggered by cars, boats, planes, or virtual environments. For most of them, this isn't a character flaw or a question of toughening up: a large portion of the variation is genetic, with twin studies estimating heritability at 57–70%¹¹ 57–70%
Reavley et al. 2006 estimated heritability at 57% (95% CI 51–63%) for a composite motion sickness score in adult twins, rising to 70% when measured retrospectively in childhood. rs10514168 is among the most clearly defined of those genetic contributors.

The variant sits downstream of TSHZ1 (Teashirt Zinc Finger Homeobox 1)²² TSHZ1 (Teashirt Zinc Finger Homeobox 1)
a transcription factor in the teashirt family, expressed during embryonic development and essential for forming the external auditory canal, middle ear ossicles, soft palate, and inner ear structures in mice and humans. Loss-of-function mutations in TSHZ1 cause congenital aural atresia³³ congenital aural atresia
absence or severe malformation of the external auditory canal, often accompanied by middle ear structural abnormalities — the most severe phenotype of TSHZ1 haploinsufficiency (OMIM 607842), an autosomal dominant condition. The implication of rs10514168 is that constitutional variation in TSHZ1 expression — far subtler than loss-of-function disease mutations — shapes the architecture of the vestibular apparatus itself, leaving some individuals with an inner ear that is structurally more sensitive to conflicting motion signals.

The Mechanism

The vestibular system of the inner ear detects head movement and body position via fluid-filled semicircular canals and otolith organs (utricle and saccule). Motion sickness is thought to arise from sensory conflict: the vestibular system signals movement while the visual system — watching a stationary car interior, for example — reports stillness. The brain's resolution of this conflict is what produces nausea and autonomic symptoms.

rs10514168 is an intergenic regulatory variant located downstream of TSHZ1 on chromosome 18. It does not change any protein sequence. Instead, by modulating TSHZ1 transcriptional activity during inner ear morphogenesis, it appears to influence the structural sensitivity of the vestibular apparatus — an innate architectural predisposition that persists throughout life. The C allele (major, protective) is associated with lower motion sickness scores; each copy of the A allele (minor) adds to constitutional susceptibility.

The Evidence

The primary evidence comes from Hromatka et al. 2015⁴⁴ Hromatka et al. 2015
Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis. Human Molecular Genetics, the first genome-wide association study of motion sickness, conducted in 80,494 individuals from the 23andMe research cohort. Participants rated their car sickness on a 0–3 scale. Thirty-five SNPs reached genome-wide significance (P < 5×10⁻⁸); rs10514168 reached P = 2.7×10⁻⁹. The C allele was protective with an effect size of β = −0.047 per allele (95% CI −0.062 to −0.031) — meaning each additional C allele reduces the motion sickness score by roughly 0.05 units on a 3-point scale. The A allele confers the complementary risk.

The TSHZ1 locus was specifically highlighted because of the gene's established role in murine inner ear development. Multiple other significant GWAS hits from the same study implicate related developmental pathways — rs12111385 near MUTED (endosomal trafficking in cochlear hair cells) and HOX gene clusters — converging on the hypothesis that motion sickness susceptibility is substantially determined by vestibular organ architecture laid down during embryogenesis.

Population frequencies show marked variation by ancestry: the A risk allele is most common in Latino/Admixed American populations (~22%), moderate in Europeans (~16%) and South Asians (~12%), less common in Africans (~6%), and rare in East Asians (~0.4%). This creates meaningful population-level differences in the baseline prevalence of high motion sickness susceptibility.

Evidence level is classified as strong: a single large GWAS (n=80,494) with genome-wide significance, biologically coherent mechanism through an established developmental gene, and independent heritability data. The variant has not yet been replicated in a second independent GWAS cohort of comparable size.

Practical Actions

Carriers of the A allele — particularly AC heterozygotes and AA homozygotes — have a constitutional vestibular susceptibility that does not resolve with time or willpower. The appropriate responses are: (1) desensitization through vestibular rehabilitation exercises, which have strong evidence for reducing vestibulo-ocular conflict responses; (2) anticipatory mitigation before travel (positioning, gaze strategies, antiemetics as needed); and (3) career counselling for individuals considering occupations with high vestibular demands such as commercial aviation, naval service, or professional maritime work, where motion sickness susceptibility affects performance and certification.

Interactions

rs10514168 is one of several motion sickness–associated GWAS hits near genes involved in inner ear development and vestibular function. rs12111385 (near MUTED, encoding an endosomal trafficking protein important for cochlear hair cell function) and rs1435985 (also near TSHZ1 in some analyses) represent related loci from the same GWAS. Individuals carrying risk alleles at multiple loci would be expected to have additive constitutional susceptibility, though compound analyses have not been published for this specific combination.

The migraine-vestibular overlap is also relevant: several motion sickness GWAS hits are near genes implicated in migraine (e.g., WNT10B locus), and vestibular migraine shares phenomenology with severe motion sickness. Carriers of both TSHZ1 risk variants and migraine-associated variants may have higher combined susceptibility to vestibular symptoms.